Ann: DEP irinotecan phase 2 commences after positive phase 1, page-10

Dep Doc, Dep Cab, Dep Irin & AZD, what a list! Additionally they plan to add 1-2 new Dep candidates each year. Their DEP technology is worth billions when / if it gets to market. the reduction in side effects alone is a company maker, improved efficacy and we are off to the races!

I know I am like a broken record on this, but get Dep Doc to complete phase II and the company will have a significant re-rate. It's proof of concept for the entire Dep portfolio. Licensing deals will flow and we can all put the last few months / years of 'extreme patience' behind us.